Table 2 Outcomes of patients with ipilimumab re-induction therapy
Age, years | Best response at week 12 (RECIST) | Duration between 1st restaging (week 12) and re-induction therapy (days) | Response at 1st restaging after re-induction (RECIST) | Best overall response after re-induction (RECIST) | Time from 1st dose to death/follow-up (months) | Alive |
|---|---|---|---|---|---|---|
74 | PR | 91 | SD | SD | 17.1 | Yes |
56 | PR | 232 | PR | CR | 25.5 | Yes |
73 | PR | 217 | PD | SD | 24.8 | Yes |